You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tumour cell mobilization

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Large Cell Lymphoma Relapsed/Refractory Trial in San Francisco (Ofatumumab, Etoposide, Cytarabine)

Completed
Has Results
  • Diffuse Large Cell Lymphoma Relapsed/Refractory
  • San Francisco, California
    University of California, San Francisco
Jun 5, 2022

Using Breath, Cell Free DNA and Image Analysis to PRedIct Normal

Recruiting
  • Prostate Cancer
  • +3 more
  • Stereotactic Body Radiotherapy
  • Edinburgh, Mid Lothian, United Kingdom
    Edinburgh Cancer Centre, Western General Hospital
Apr 5, 2022

Non-interventional, Long-term Safety Data Collection of Zarzio®

Active, not recruiting
  • Hematopoietic Stem Cell Mobilization
    • Frankfurt/Main, Hessen, Germany
    • +1 more
    Jan 24, 2022

    Multiple Myeloma Trial (GPC-100, Propranolol, G-CSF)

    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    Sep 29, 2022

    Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, [89Zr]Zr-BI 764532)

    Not yet recruiting
    • Small Cell Lung Carcinoma (SCLC)
    • Neuroendocrine Neoplasms
    • BI 764532
    • [89Zr]Zr-BI 764532
    • (no location specified)
    Jul 31, 2023

    Cancer, Cancer of Lung Trial in Herlev (Exercise intervention, Standard oncological treatments)

    Recruiting
    • Cancer
    • Cancer of Lung
    • Exercise intervention
    • Standard oncological treatments
    • Herlev, Denmark
      Herlev Hospital
    Mar 16, 2022

    Extra Cranial Non Seminomateous Malignant Germ Cell Tumour Trial in France (Velbe-Bleomycin-Cisplatin,

    Completed
    • Extra Cranial Non Seminomateous Malignant Germ Cell Tumour
    • Amiens, France
    • +26 more
    Aug 26, 2022

    Sickle Cell Disease Trial in New York (Plerixafor)

    Recruiting
    • Sickle Cell Disease
    • New York, New York
    • +1 more
    Mar 21, 2022

    Pathological Tumor and Lymph Node Responses After Neoadjuvant

    Completed
    • Non Small Cell Lung Cancer
    • +3 more
    • Timing of drug administration
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Nov 24, 2022

    NSCLC Trial in Manchester (therascreen® KRAS RGQ PCR Kit)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • therascreen® KRAS RGQ PCR Kit
    • Manchester, United Kingdom
      QIAGEN Gaithersburg, Inc
    Apr 20, 2022

    Autologous Haematopoietic Stem Cell Transplant Trial in China (plerixafor + G-CSF)

    Recruiting
    • Autologous Haematopoietic Stem Cell Transplant
    • plerixafor + G-CSF
    • China, China
      Investigational Sites
    May 4, 2022

    NSCLC, Stage IV, Oligometastasis Trial in Netherlands, Spain, Switzerland (drug, radiation, procedure)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • +2 more
    • Milano, Italy
    • +12 more
    Dec 14, 2022

    Advanced Solid Tumours Trial in United States (AZD9150, Durvalumab, Cisplatin)

    Active, not recruiting
    • Advanced Solid Tumours
    • Lafayette, Indiana
    • +5 more
    Jul 22, 2022

    NSCLC Trial in Ostrava (primary tumour radiotherapy, stereotactic body radiotherapy, maintenance radiotherapy)

    Recruiting
    • Non-small Cell Lung Cancer
    • primary tumour radiotherapy
    • +2 more
    • Ostrava, Moravian-Silesian Region, Czechia
      University Hospital Ostrava
    Dec 6, 2022

    Sickle Cell Disease Trial in Boston, Memphis (MGTA-145, Plerixafor)

    Recruiting
    • Sickle Cell Disease
    • Bethesda, Maryland
    • +2 more
    Nov 4, 2022

    Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, Non-Small Cell Carcinoma of Lung, TNM Stage 4 Trial in France

    Recruiting
    • Non Small Cell Lung Cancer
    • +2 more
    • Radiotherapy
    • +2 more
    • Angers, France
    • +25 more
    Jul 25, 2022

    NSCLC Trial in Japan, Korea, Republic of, United States (Gefitinib, MEDI4736)

    Completed
    • Carcinoma, Non-Small-Cell Lung
    • Tampa, Florida
    • +6 more
    Mar 22, 2022

    Stem Cell Transplant Complications Trial in Edmonton (Loratadine, Placebo)

    Not yet recruiting
    • Stem Cell Transplant Complications
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    Jun 13, 2022

    NSCLC Trial in Tianjin (Ensartinib, Placebo)

    Recruiting
    • Non-small Cell Lung Cancer
    • Tianjin, China
      TianJin Medical University Cancer Institute & Hospital
    Jul 13, 2022

    Stage IV NSCLC Trial in Heerlen, Maastricht (No interventions)

    Completed
    • Stage IV Non-small Cell Lung Cancer
    • No interventions
    • Heerlen, Netherlands
    • +1 more
    Sep 15, 2021

    Multiple Myeloma Trial in Berne (Vinorelbine, Gemcitabine, G-CSF)

    Recruiting
    • Multiple Myeloma
    • Berne, Switzerland
      Department for Medical Oncology University Hospital/Inselspital
    Jul 29, 2021

    Circulating Tumor Cell, Hepatocellular Carcinoma Trial in Hong Kong (Propofol, Sevoflurane)

    Unknown status
    • Circulating Tumor Cell
    • Hepatocellular Carcinoma
    • Hong Kong, Guangdong, China
      HKU Li Ka Shing Faculty of Medicine
    Sep 28, 2021

    Related Donors Donating PBSC to a Family Member, Healthy Donors, Acute Myelogenous Leukemia Trial in United States (MGTA-145,

    Terminated
    • Related Donors Donating PBSC to a Family Member
    • +4 more
    • MGTA-145
    • Plerixafor
    • Duarte, California
    • +7 more
    Apr 13, 2022

    BIOREN (Predictive BIOmarkers in Metastatic RENal Cancer)

    Recruiting
    • Renal Cancer Metastatic
    • Immunological and tumour characterization
    • Lyon, France
      Centre Leon Berard
    Mar 14, 2022

    Healthy Participants Trial in United States (Tbo-filgrastim)

    Terminated
    Has Results
    • Healthy Participants
    • Duarte, California
    • +8 more
    Dec 16, 2021